Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma

Authors

• Erica K Barnell, Washington University School of Medicine in St. Louis
• Zachary L Skidmore, Washington University School of Medicine in St. Louis
• Kenneth F Newcomer, Washington University School of Medicine in St. Louis
• Monique Chavez, Washington University School of Medicine in St. Louis
• Katie M Campbell, Washington University School of Medicine in St. Louis
• Kelsy C Cotto, Washington University School of Medicine in St. Louis
• Nicholas C Spies, Washington University School of Medicine in St. Louis
• Marianna B Ruzinova, Washington University School of Medicine in St. Louis
• Tianjiao Wang, Washington University School of Medicine in St. Louis
• Brooj Abro, Washington University School of Medicine in St. Louis
• Bijal A Parikh, Washington University School of Medicine in St. Louis
• Eric J Duncavage, Washington University School of Medicine in St. Louis
• John L Frater, Washington University School of Medicine in St. Louis
• Yi-Shan Lee, Washington University School of Medicine in St. Louis
• Anjum Hassan, Washington University School of Medicine in St. Louis
• Justin A King, Washington University School of Medicine in St. Louis
• Daniel R Kohnen, Washington University School of Medicine in St. Louis
• Mark A Fiala, Washington University School of Medicine in St. Louis
• John S Welch, Washington University School of Medicine in St. Louis
• Geoffrey L Uy, Washington University School of Medicine in St. Louis
• Kiran Vij, Washington University School of Medicine in St. Louis
• Ravi Vij, Washington University School of Medicine in St. Louis
• Malachi Griffith, Washington University School of Medicine in St. Louis
• Obi L Griffith, Washington University School of Medicine in St. Louis
• Lukas D Wartman, Washington University School of Medicine in St. Louis
• et al.

Journal

Blood Advances

Publication Date

1-24-2023

Volume

7

Issue

2

First Page

236

Last Page

245

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2022007496

Rights and Permissions

Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, Spies NC, Ruzinova MB, Wang T, Abro B, Kreisel F, Parikh BA, Duncavage EJ, Frater JL, Lee YS, Hassan A, King JA, Kohnen DR, Fiala MA, Welch JS, Uy GL, Vij K, Vij R, Griffith M, Griffith OL, Wartman LD. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. Blood Adv. 2023 Jan 24;7(2):236-245. doi: 10.1182/bloodadvances.2022007496. © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Recommended Citation

Barnell, Erica K; Skidmore, Zachary L; Newcomer, Kenneth F; Chavez, Monique; Campbell, Katie M; Cotto, Kelsy C; Spies, Nicholas C; Ruzinova, Marianna B; Wang, Tianjiao; Abro, Brooj; Parikh, Bijal A; Duncavage, Eric J; Frater, John L; Lee, Yi-Shan; Hassan, Anjum; King, Justin A; Kohnen, Daniel R; Fiala, Mark A; Welch, John S; Uy, Geoffrey L; Vij, Kiran; Vij, Ravi; Griffith, Malachi; Griffith, Obi L; Wartman, Lukas D; and et al., "Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma." Blood Advances. 7, 2. 236 - 245. (2023).
https://digitalcommons.wustl.edu/oa_4/1378

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.